Scientific article
OA Policy
English

Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children

Published in

Therapeutic Drug Monitoring, vol. 42, no. 1, p. 111-117

Publication date

2020

Abstract

Busulfan (Bu) is one of the conditioning regimen components for pediatric hematopoietic stem cell transplantation. Bu therapeutic drug monitoring (TDM) is essential for a successful treatment outcome and toxicity evasion. Dried blood spot (DBS) sampling is a rapid and simple method for Bu TDM, compared with conventional plasma sampling. This study evaluated the feasibility of using the DBS method for Bu TDM. The hematocrit (Hct) and conditioning day were also examined for their impact on the DBS method's performance.

Keywords

  • TDM
  • Dried blood spot
  • Busulfan
  • Children
  • Pharmacokinetics

Citation (ISO format)

DILO, Ana et al. Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children. In: Therapeutic Drug Monitoring, 2020, vol. 42, n° 1, p. 111–117. doi: 10.1097/FTD.0000000000000673

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0163-4356
466views
267downloads

Technical informations

Creation

28/10/2020 11:50:00

First validation

28/10/2020 11:50:00

Update

13/10/2025 16:53:53

Status update

15/03/2023 22:58:14

Last indexation

29/10/2026 12:20:16
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated